Inspire Medical Systems, Inc. Increase (Decrease) in Accounts Payable
Inspire Medical Systems, Inc. (INSP) reported Increase (Decrease) in Accounts Payable of -$6.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-03
- Inspire Medical Systems, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$13.83M, a 164.83% decline year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $7.13M.
- Inspire Medical Systems, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$22.10M, a 657.89% decline year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $6.54M, a 296.78% increase year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$3.75M, a 720.36% decline from fiscal 2024.
- Inspire Medical Systems, Inc. increase (decrease) in accounts payable for fiscal 2024 was $604.00K, a 93.50% decline from fiscal 2023.
- Inspire Medical Systems, Inc. increase (decrease) in accounts payable for fiscal 2023 was $9.30M, a 35.24% decline from fiscal 2022.
- Inspire Medical Systems, Inc. increase (decrease) in accounts payable for fiscal 2022 was $14.36M, a 200.38% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$13.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$6.70M 10-Q · filed 2026-08-03 | -$28.80M derived: sum of 3 quarters · filed 2026-08-03 | -$22.26M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $7.13M 10-Q · filed 2026-05-04 | -$14.97M derived: sum of 2 quarters · filed 2026-05-04 | -$8.43M derived: sum of 3 quarters · filed 2026-05-04 | $12.90M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$22.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$15.56M derived: sum of 2 quarters · filed 2026-02-13 | $5.77M derived: sum of 3 quarters · filed 2026-08-03 | -$3.75M 10-K · filed 2026-02-13 |
| 2025-09-30 | $6.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $27.87M derived: sum of 2 quarters · filed 2026-08-03 | $18.35M 10-Q · filed 2025-11-03 | $22.31M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $21.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $11.82M 10-Q · filed 2026-08-03 | $15.78M derived: sum of 3 quarters · filed 2026-08-03 | $17.42M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$9.52M 10-Q · filed 2026-05-04 | -$5.56M derived: sum of 2 quarters · filed 2026-05-04 | -$3.91M derived: sum of 3 quarters · filed 2026-05-04 | -$12.47M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $5.61M derived: sum of 2 quarters · filed 2026-02-13 | -$2.95M derived: sum of 3 quarters · filed 2026-02-13 | $604.00K 10-K · filed 2026-02-13 |
| 2024-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$6.92M derived: sum of 2 quarters · filed 2025-11-03 | -$3.36M 10-Q · filed 2025-11-03 | -$5.14M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | -$8.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$5.00M 10-Q · filed 2025-08-04 | -$6.78M derived: sum of 3 quarters · filed 2026-02-13 | -$7.49M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $3.56M 10-Q · filed 2025-05-05 | $1.78M derived: sum of 2 quarters · filed 2026-02-13 | $1.07M derived: sum of 3 quarters · filed 2026-02-13 | $4.46M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$2.49M derived: sum of 2 quarters · filed 2026-02-13 | $906.00K derived: sum of 3 quarters · filed 2026-02-13 | $9.30M 10-K · filed 2026-02-13 |
| 2023-09-30 | -$707.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $2.69M derived: sum of 2 quarters · filed 2024-11-04 | $11.07M 10-Q · filed 2024-11-04 | $16.83M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $3.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $11.78M 10-Q · filed 2024-08-06 | $17.54M derived: sum of 3 quarters · filed 2025-02-10 | $22.38M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $8.39M 10-Q · filed 2024-05-07 | $14.14M derived: sum of 2 quarters · filed 2025-02-10 | $18.99M derived: sum of 3 quarters · filed 2025-02-10 | $17.23M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $5.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $10.60M derived: sum of 2 quarters · filed 2025-02-10 | $8.84M derived: sum of 3 quarters · filed 2025-02-10 | $14.36M 10-K · filed 2025-02-10 |
| 2022-09-30 | $4.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.08M derived: sum of 2 quarters · filed 2023-11-07 | $8.60M 10-Q · filed 2023-11-07 | $9.89M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | -$1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $3.75M 10-Q · filed 2023-08-01 | $5.04M derived: sum of 3 quarters · filed 2024-02-09 | $6.34M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | $5.52M 10-Q · filed 2023-05-02 | $6.81M derived: sum of 2 quarters · filed 2024-02-09 | $8.11M derived: sum of 3 quarters · filed 2024-02-09 | $8.82M derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $2.59M derived: sum of 2 quarters · filed 2024-02-09 | $3.30M derived: sum of 3 quarters · filed 2024-02-09 | $4.78M 10-K · filed 2024-02-09 |
| 2021-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $2.01M derived: sum of 2 quarters · filed 2022-11-01 | $3.49M 10-Q · filed 2022-11-01 | $3.28M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $712.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $2.19M 10-Q · filed 2022-08-02 | $1.98M derived: sum of 3 quarters · filed 2023-02-10 | $3.60M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $1.48M 10-Q · filed 2022-05-03 | $1.26M derived: sum of 2 quarters · filed 2023-02-10 | $2.89M derived: sum of 3 quarters · filed 2023-02-10 | $2.15M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | -$214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $1.41M derived: sum of 2 quarters · filed 2023-02-10 | $676.00K derived: sum of 3 quarters · filed 2023-02-10 | $2.05M 10-K · filed 2023-02-10 |
| 2020-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $890.00K derived: sum of 2 quarters · filed 2021-11-02 | $2.26M 10-Q · filed 2021-11-02 | $1.85M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$733.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $639.00K 10-Q · filed 2021-08-03 | $229.00K derived: sum of 3 quarters · filed 2022-02-15 | $2.42M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $1.37M 10-Q · filed 2021-05-04 | $962.00K derived: sum of 2 quarters · filed 2022-02-15 | $3.15M derived: sum of 3 quarters · filed 2022-02-15 | $2.63M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | -$410.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.78M derived: sum of 2 quarters · filed 2022-02-15 | $1.26M derived: sum of 3 quarters · filed 2022-02-15 | $1.03M 10-K · filed 2022-02-15 |
| 2019-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $1.67M derived: sum of 2 quarters · filed 2020-11-02 | $1.44M 10-Q · filed 2020-11-02 | $2.43M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$523.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$745.00K 10-Q · filed 2020-08-04 | $243.00K derived: sum of 3 quarters · filed 2021-02-24 | $447.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$222.00K 10-Q · filed 2020-05-05 | $766.00K derived: sum of 2 quarters · filed 2021-02-24 | $970.00K derived: sum of 3 quarters · filed 2021-02-24 | -$701.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $988.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.19M derived: sum of 2 quarters · filed 2021-02-24 | -$479.00K derived: sum of 3 quarters · filed 2021-02-24 | $439.00K 10-K · filed 2021-02-24 |
| 2018-09-30 | $204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$1.47M derived: sum of 2 quarters · filed 2019-11-05 | -$549.00K 10-Q · filed 2019-11-05 | $831.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$753.00K 10-Q · filed 2019-08-06 | $627.00K derived: sum of 3 quarters · filed 2020-02-25 | $895.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $918.00K 10-Q · filed 2019-05-07 | $2.30M derived: sum of 2 quarters · filed 2020-02-25 | $2.57M derived: sum of 3 quarters · filed 2020-02-25 | $2.62M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.65M derived: sum of 2 quarters · filed 2020-02-25 | $1.70M derived: sum of 3 quarters · filed 2020-02-25 | $1.82M 10-K · filed 2020-02-25 |
| 2017-09-30 | $268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $318.00K derived: sum of 2 quarters · filed 2018-11-06 | $445.00K 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $177.00K 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $127.00K 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | -$480.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |